ACE2 Overexpression Inhibits Acquired Platinum Resistance-Induced Tumor Angiogenesis in NSCLC

Oncology Reports - Greece
doi 10.3892/or.2016.4967
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Overexpression of Wnt5a Promotes Angiogenesis in NSCLC

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

RACK1 Overexpression Is Linked to Acquired Imatinib Resistance in Gastrointestinal Stromal Tumor

Oncotarget
Oncology
2016English

ACE2 Overexpression in the Paraventricular Nucleus Attenuates Angiotensin II-induced Hypertension

Cardiovascular Research
Cardiovascular MedicinePhysiologyCardiology
2011English

P1.13-13 Potent Anti-Tumor Effect of Ganetespib in Acquired EGFR-TKI Resistance NSCLC Cells

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Neomycin Inhibits Angiogenin-Induced Angiogenesis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

Genomic Imbalances Associated With Acquired Resistance to Platinum Analogues

American Journal of Pathology
Forensic MedicinePathology
1999English

HdmX Overexpression Inhibits Oncogene Induced Cellular Senescence

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2010English

Zerumbone Inhibits Tumor Angiogenesis via NF-κB in Gastric Cancer

Oncology Reports
MedicineCancer ResearchOncology
2013English

Mutant-Selective Irreversible EGFR Inhibitor, Naquotinib, Inhibits Tumor Growth in NSCLC Models With EGFR Activating Mutations, T790M Mutation and AXL Overexpression

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy